Background: The pleiotropic pro-inflammatory cytokine Interleukin (IL)-18 has been proposed to play a role in schizophrenia, since elevated circulating levels of its protein and altered frequencies of genetic variants in its molecular system are reported in schizophrenic patients.Methods: We analyzed 77 patients with schizophrenia diagnosis (SCZ) and 77 healthy control subjects (HC) for serum concentration of both IL-18 and its natural inhibitor, the IL-18 binding protein (IL-18BP).Results: We confirmed that serum levels of total IL-18 are significantly increased in SCZ, as compared to HC. However, due to a highly significant increase in levels of circulating IL-18BP in SCZ, as compared to HC, the levels of free, bioactive IL-18 are not significantly different between the two groups. In addition, the relationships between the levels of IL-18 and its inhibitor, as well as between the two molecules and age appear dissimilar for SCZ and HC. In particular, the elevated levels of IL-18BP, likely a consequence of the body's attempt to counteract the early prominent inflammation which characterizes schizophrenia, are maintained in earlier and later stages of the disease. However, the IL-18BP elevation appears ineffective to balance the IL-18 system in younger SCZ patients, while in older patients the levels of circulating bioactive IL-18 are comparable to those of HC, if not lower.Conclusions: In conclusion, these findings indicate that the IL-18 system is perturbed in schizophrenia, supporting the idea that this pro-inflammatory cytokine might be part of a pathway of genetic and environmental components for vulnerability to the disease. © 2012 Palladino et al.; licensee BioMed Central Ltd.
Palladino, I., Salani, F., Ciaramella, A., Rubino, I.A., Caltagirone, C., Fagioli, S., et al. (2012). Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia. JOURNAL OF NEUROINFLAMMATION, 9(1), 206 [10.1186/1742-2094-9-206].
|Titolo:||Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia|
|Data di pubblicazione:||2012|
|Citazione:||Palladino, I., Salani, F., Ciaramella, A., Rubino, I.A., Caltagirone, C., Fagioli, S., et al. (2012). Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia. JOURNAL OF NEUROINFLAMMATION, 9(1), 206 [10.1186/1742-2094-9-206].|
|Appare nelle tipologie:||1.1 Articolo in rivista|